-
-
-
-
-
-
-
UPDATE: Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/17: (LXRX) (TSLA) (YY) Higher; (BCLI) (GDRX) (CODX) Lower (more...)
-
-
-
-
-
-
-
Lexicon Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides a Business Update
-
-
-
-
-
-
-
Lexicon Pharmaceuticals Reports First Quarter 2017 Financial Results And Provides A Business Update
-
-
-
-
-
-
-
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2016 Third Quarter Financial Results
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/06: (ZSPH) (LXRX) (WTW) Higher; (ICON) (MW) (KBIO) Lower (more...)
-
-
-
-
-
-
-
Ipsen’s Partner, Lexicon Pharmaceuticals, Announces Positive Results from TELESTAR Phase 3 Study Showing That Telotristat Etiprate is Effective in the Treatment of Carcinoid Syndrome Caused by Neuro
-
1,155,357 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

